A detailed history of Credit Suisse Ag transactions in Johnson & Johnson stock. As of the latest transaction made, Credit Suisse Ag holds 5,791,703 shares of JNJ stock, worth $845 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares
5,791,703
Previous 6,183,535 6.34%
Holding current value
$845 Million
Previous $969 Million 5.47%
% of portfolio
0.91%
Previous 0.96%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$155.22 - $162.74 $60.8 Million - $63.8 Million
-391,832 Reduced 6.34%
5,791,703 $916 Million
Q4 2023

Feb 08, 2024

SELL
$145.6 - $158.88 $69.5 Million - $75.9 Million
-477,561 Reduced 7.17%
6,183,535 $969 Million
Q3 2023

Nov 13, 2023

SELL
$155.75 - $174.48 $38.2 Million - $42.8 Million
-245,478 Reduced 3.55%
6,661,096 $1.04 Billion
Q2 2023

Aug 11, 2023

SELL
$154.35 - $166.11 $28.1 Million - $30.2 Million
-182,055 Reduced 2.57%
6,906,574 $1.14 Billion
Q1 2023

May 10, 2023

SELL
$151.05 - $180.26 $7.03 Million - $8.39 Million
-46,551 Reduced 0.65%
7,088,629 $1.1 Billion
Q4 2022

Feb 13, 2023

BUY
$160.2 - $179.79 $10.3 Million - $11.5 Million
64,103 Added 0.91%
7,135,180 $1.26 Billion
Q3 2022

Nov 10, 2022

SELL
$161.33 - $179.52 $3.72 Million - $4.14 Million
-23,056 Reduced 0.33%
7,071,077 $1.16 Billion
Q2 2022

Aug 12, 2022

BUY
$168.19 - $186.01 $20.5 Million - $22.6 Million
121,713 Added 1.75%
7,094,133 $1.26 Billion
Q1 2022

May 16, 2022

BUY
$158.14 - $179.59 $112 Million - $127 Million
706,237 Added 11.27%
6,972,420 $1.24 Billion
Q4 2021

Feb 14, 2022

BUY
$155.93 - $173.01 $9.81 Million - $10.9 Million
62,902 Added 1.01%
6,266,183 $1.07 Billion
Q3 2021

Nov 12, 2021

SELL
$161.5 - $179.47 $25.1 Million - $27.8 Million
-155,144 Reduced 2.44%
6,203,281 $1 Billion
Q2 2021

Aug 16, 2021

SELL
$159.48 - $171.07 $29 Million - $31.1 Million
-181,595 Reduced 2.78%
6,358,425 $1.04 Billion
Q1 2021

May 14, 2021

BUY
$153.07 - $170.48 $65.4 Million - $72.9 Million
427,421 Added 6.99%
6,540,020 $1.07 Billion
Q4 2020

Feb 12, 2021

BUY
$137.11 - $157.38 $21.7 Million - $25 Million
158,580 Added 2.66%
6,112,599 $962 Million
Q3 2020

Nov 13, 2020

BUY
$140.38 - $153.83 $18 Million - $19.7 Million
127,892 Added 2.2%
5,954,019 $886 Million
Q2 2020

Aug 12, 2020

BUY
$128.81 - $155.51 $16.2 Million - $19.6 Million
125,862 Added 2.21%
5,826,127 $819 Million
Q1 2020

May 13, 2020

SELL
$111.14 - $153.99 $24 Million - $33.3 Million
-216,280 Reduced 3.66%
5,700,265 $747 Million
Q4 2019

Feb 12, 2020

BUY
$127.5 - $146.44 $103 Million - $118 Million
807,729 Added 15.81%
5,916,545 $863 Million
Q3 2019

Nov 12, 2019

BUY
$126.95 - $142.14 $27.3 Million - $30.6 Million
215,099 Added 4.4%
5,108,816 $661 Million
Q2 2019

Aug 14, 2019

BUY
$131.15 - $144.24 $25.9 Million - $28.5 Million
197,752 Added 4.21%
4,893,717 $682 Million
Q1 2019

May 14, 2019

SELL
$125.72 - $139.79 $93.1 Million - $104 Million
-740,623 Reduced 13.62%
4,695,965 $656 Million
Q4 2018

Feb 13, 2019

SELL
$122.84 - $147.84 $39.5 Million - $47.5 Million
-321,180 Reduced 5.58%
5,436,588 $702 Million
Q3 2018

Nov 13, 2018

BUY
$121.58 - $142.88 $27.4 Million - $32.2 Million
225,433 Added 4.07%
5,757,768 $796 Million
Q2 2018

Aug 14, 2018

BUY
$119.4 - $131.76 $101 Million - $111 Million
843,441 Added 17.99%
5,532,335 $671 Million
Q1 2018

May 15, 2018

SELL
$125.1 - $148.14 $47 Million - $55.6 Million
-375,516 Reduced 7.41%
4,688,894 $601 Million
Q4 2017

Mar 14, 2018

BUY
$131.22 - $143.62 $21.3 Million - $23.4 Million
162,648 Added 3.32%
5,064,410 $708 Million
Q4 2017

Feb 14, 2018

BUY
$131.22 - $143.62 $38.1 Million - $41.7 Million
290,524 Added 6.3%
4,901,762 $685 Million
Q3 2017

Nov 14, 2017

SELL
$129.47 - $135.38 $37.2 Million - $38.9 Million
-287,324 Reduced 5.87%
4,611,238 $600 Million
Q2 2017

Aug 14, 2017

BUY
N/A
4,898,562
4,898,562 $648 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.